GLP-1 drugs, originally developed to treat diabetes and now widely used for obesity, are reshaping healthcare in the US. As research uncovers potential benefits beyond weight loss, experts are asking whether these medications could one day be used far more widely.
Subscribe to our channel: http://bit.ly/AJSubscribe
Follow us on X : https://twitter.com/AJEnglish
Find us on Facebook: https://www.facebook.com/aljazeera
Check our website: http://www.aljazeera.com/
Check out our Instagram page: https://www.instagram.com/aljazeeraenglish/
Download AJE Mobile App: https://aje.news/AJEMobile
